Why epilepsy may be hard to control in children
Part of Brain & nervous system clinical trials.
This trial looks at children with epilepsy to find out what makes some cases harder to treat with medicine. It may help doctors understand why seizures continue in some kids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 1 to 18 years old
- You have been diagnosed with epilepsy by a doctor
- Your seizures are not controlled by current medicines
- Your parents or guardians agree to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized brain stimulation method (transcranial electrical stimulation) to reduce seizures in children with hard-to-control partial epilepsy. It aims to find the best stimulation spot and settings for each patient by using advanced brain scans.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This trial tests if adding cannabidiol (CBD) to your child's current seizure medicines can reduce seizures. It uses a personalized approach to see if CBD works for each child.
This trial studies ESIS in children and teens (ages 1 to 30) who have epilepsy that has not been controlled by medications. It may help by improving how doctors evaluate and treat seizures, especially when an additional brain-monitoring test is planned.
This study looks at how well the kidneys work in children who have epilepsy. It may help doctors understand how epilepsy or its treatment affects kidney health.
This trial looks at using brain surgery to treat epilepsy that does not improve with usual medicines, or epilepsy caused by a brain tumor. It may help some people reduce seizures if surgery is appropriate for their situation.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.